(Cyclohexylmethyl)pyrazine
Common Name: |
(Cyclohexylmethyl)pyrazine |
IUPAC Name: |
2-(cyclohexylmethyl)pyrazine |
Molecular Formula: |
C11H18O2 |
SMILES: |
C1CCC(CC1)CC2=NC=CN=C2 |
Inchi: |
1S/C11H16N2/c1-2-4-10(5-3-1)8-11-9-12-6-7-13-11/h6-7,9-10H,1-5,8H2 |
Inchi Key: |
DGJZDAIWCSVZBI-UHFFFAOYSA-N |
Cas No: |
28217-92-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
182.26 |
Mass (g/mol) |
176.131 |
Molar Refractivity |
55.33 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
6 |
Rings |
2 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
100.00 @ 4.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.0104 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.55 |
LogP |
2.599 |
iLOGP |
3.10 |
XLOGP3 |
3.10 |
WLOGP |
2.71 |
MLOGP |
2.67 |
ESOL Log S |
-2.53 |
ESOL Solubility (mg/ml) |
0.542 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.32 |
Ali Solubility (mg/ml) |
0.09 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.12 |
Silicos-IT Solubility (mg/ml) |
1.37 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.21 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.379 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.506 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |